{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319367303424.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0022-510x(01)00563-9"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022510X01005639?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022510X01005639?httpAccept=text/plain"}}],"dc:title":[{"@value":"Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319367303425","@type":"Researcher","foaf:name":[{"@value":"Mauro Mondelli"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319367303427","@type":"Researcher","foaf:name":[{"@value":"Francesco Sicurelli"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319367303426","@type":"Researcher","foaf:name":[{"@value":"Chiara Scarpini"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319367303424","@type":"Researcher","foaf:name":[{"@value":"Maria Teresa Dotti"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319367303552","@type":"Researcher","foaf:name":[{"@value":"Antonio Federico"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0022510X"}],"prism:publicationName":[{"@value":"Journal of the Neurological Sciences"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2001-09","prism:volume":"190","prism:number":"1-2","prism:startingPage":"29","prism:endingPage":"33"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022510X01005639?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022510X01005639?httpAccept=text/plain"}],"createdAt":"2002-07-25","modifiedAt":"2021-05-08","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360567183411499904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nationwide survey on cerebrotendinous xanthomatosis in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680017130368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"ミトコンドリア病と鑑別を要する臨床表現型を呈し<i>CYP27A1</i>遺伝子エクソン1に新規フレームシフト変異（c. 43_44delGG）を認めた脳腱黄色腫症の1例"},{"@language":"en","@value":"A case of cerebrotendinous xanthomatosis mimicking the clinical phenotype of mitochondrial disease with a novel frame-shift mutation (c. 43_44 delGG) in <i>CYP27A1</i> gene exon 1"}]},{"@id":"https://cir.nii.ac.jp/crid/1390289232190247680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0022-510x(01)00563-9"},{"@type":"CROSSREF","@value":"10.1038/s10038-017-0389-4_references_DOI_RHg2UdsicJyW7h45HyZimoV46dD"},{"@type":"CROSSREF","@value":"10.5551/jat.rv17055_references_DOI_RHg2UdsicJyW7h45HyZimoV46dD"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-000823_references_DOI_RHg2UdsicJyW7h45HyZimoV46dD"}]}